New research, from scientists at Imperial College London, unravels how so-called bacterial persister cells manipulate our immune cells.

The work potentially opens new avenues to finding ways of clearing these bacterial cells from the body, and stopping recurrence of the bacterial infection.

The latest findings, published in the journal Science, may help explain why some people suffer from repeated bouts of an illness, despite taking antibiotics. In the study, funded by the Medical Research Council, the Lister Institute and EMBO, the scientists, in collaboration with the Vogel lab at the Helmholtz Institute for RNA-based Infection Research (a site of the Helmholtz Centre for Infection Research) in Germany, studied bacterial cells of Salmonella called persisters.

Previously, it was thought persisters are completely dormant. However the reality we revealed here is much scarier. Dr Peter Hill Study author

Whenever bacteria such as Salmonella invade the body, many of the bugs enter a type of stand-by mode in response to attack by the body immune system, which means they are not killed by antibiotics.

These bacteria persister cells stop replicating and can remain in this dormant, ‘sleeper-cell’ state for days, weeks or even months. When antibiotic treatment has been stopped, if some of these bacterial cells spring back to life, they can trigger another infection.

Dr Sophie Helaine, senior author of the research from the MRC Centre for Molecular Bacteriology and Infection in Imperial’s Department of Medicine explained: “Persisters are often the culprit for repeat or hard-to-treat infections. The classic scenario is a person suffers some type of illness – such as a urinary tract infection or ear infection, and takes antibiotics that stop the symptoms, only for infection to return a few weeks later.”

These persister cells are formed when bacteria are taken up by macrophages, which are human immune cells that have a key role in protecting the body against infections by engulfing bacteria and viruses. Once inside the macrophage, the persister can exist in this state in which antibiotics can’t kill it for weeks, or even months.

Time-bomb for infection

Persisters were discovered in 1944 and were thought to be dormant inactive bacteria lying low in the body, acting as time bomb for relapse.

In the latest research, the scientists reveal that the persisters, while hiding in the body’s immune cells, are actually able to weaken the killing ability of the macrophages.

Dr Peter Hill, joint first co-author of the research together with joint first co-author Dr Daphne Stapels, explained: “Previously, it was thought the persisters are completely dormant. However the reality we revealed here is much scarier. They chip away at the defences from the inside, weakening the power of the macrophages – which are a key part of our arsenal against infection. This means that once antibiotic treatment stops, they might have created a much more favourable environment for another bout of infection, or even a completely new infection from another bacteria or virus.”

Bacterial weakness

Although scientists studied Salmonella infection of mouse macrophages in this research, many types of bacteria that commonly cause illness are known to form persisters in humans, including E.coli and the bacillus responsible for tuberculosis and Salmonella itself.

The scientists are now investigating whether there is any way of turning the tables against the bacteria, and if they can target the mechanism by which the persisters weaken our immune cells.

Dr Helaine added: “Although these findings suggest the persisters have a more profound effect on our immune defences than previously thought, they also reveal a potential bacterial weakness. Persisters are hard to treat as they are invisible to antibiotics, but it may be this mechanism of weakening our immune cells could be a vulnerability of these persisters. We could potentially target this mechanism, and more efficiently clear hard-to-treat infections.”

-

"Salmonella persisters undermine host immune defenses during antibiotic treatment" is published in the journal Science

See the press release of this article